MedPath

Evaluation of aspirin resistance in different doses of aspiri

Not Applicable
Conditions
Aspirin resistance.
Salicylates
Registration Number
IRCT201202026958N3
Lead Sponsor
orestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
370
Inclusion Criteria

All participants 35 years old and older , who are living in Borujerd city.Participants should have used ASA at least for 5 days.
Exclusion criteria: History of acquired or congenital coagulation disorders ,chronic kidney diseases and blood discrasia were excluded from the study. Consumption of some medications such as other platelet inhibitors and anticoagulants such as warfarin ; and volunteers with platelet count less than 150000.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding time and urinary thromboxane B2. Timepoint: Once , after intervention. Method of measurement: IVY method.;Thromboxane B2. Timepoint: Once after intervention. Method of measurement: Urinary sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath